| Medical and Health Sciences | Lifetime | 403 | NL 6 | 99.98 |
| Psychology and Behavioral Sciences | Lifetime | 109 | NL 3 | 99.96 |
| Psychology and Behavioral Sciences | 2021-2025 | 21 | NL 2 | 99.94 |
| Biological Sciences | 2021-2025 | 720 | NL 11 | 99.24 |
| Cognitive Psychology | Lifetime | 49 | NL 3 | 99.85 |
| Clinical Psychology | Lifetime | 137 | NL 5 | 99.84 |
| Biological Psychiatry | Lifetime | 5 | NL 1 | 99.65 |
| Health | Lifetime | 52 | NL 4 | 99.61 |
| Medical Physiology | Lifetime | 376 | NL 6 | 99.38 |
| Cardiology and Cardiovascular Medicine | Lifetime | 399 | NL 12 | 99.48 |
| General Health Professions | Lifetime | 819 | NL 29 | 99.07 |
| Clinical Pharmacology | Lifetime | 291 | NL 11 | 98.79 |
| Behavioral Neuroscience | Lifetime | 54 | NL 3 | 98.85 |
| Psychiatry and Mental health | Lifetime | 340 | NL 7 | 98.91 |
| Social Psychology | Lifetime | 733 | NL 27 | 98.75 |
| Aging | Lifetime | 256 | NL 9 | 82.65 |
| Cognitive Psychology | 2021-2025 | 11 | NL 4 | 99.77 |
| Clinical Psychology | 2021-2025 | 54 | NL 4 | 99.66 |
| Biological Psychiatry | 2021-2025 | 3 | NL 1 | 99.29 |
| Behavioral Neuroscience | 2021-2025 | 15 | NL 2 | 95.56 |
| Psychiatry and Mental health | 2021-2025 | 372 | NL 10 | 90.39 |
| Cognitive Neuroscience | 2021-2025 | 567 | NL 23 | 88.95 |
| Medical Physiology | 2021-2025 | 891 | NL 18 | 85.11 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 798 | NL 34 | 84.36 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 745 | NL 18 | 82.08 |
| Tryptophan and brain disorders | Lifetime | 3 | NL 1 | 99.96 |
| Cardiac Health and Mental Health | Lifetime | 3 | NL 1 | 99.93 |
| Mental Health Research Topics | Lifetime | 10 | NL 3 | 99.90 |
| Stress Responses and Cortisol | Lifetime | 16 | NL 2 | 99.89 |
| Health disparities and outcomes | Lifetime | 32 | NL 3 | 99.75 |
| Health, psychology, and well-being | Lifetime | 12 | NL 1 | 99.64 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | Lifetime | 38 | NL 2 | 99.64 |
| COVID-19 and Mental Health | Lifetime | 71 | NL 3 | 99.12 |
| Child and Adolescent Psychosocial and Emotional Development | Lifetime | 134 | NL 8 | 99.68 |
| Mental Health Treatment and Access | Lifetime | 78 | NL 4 | 99.53 |
| Treatment of Major Depression | Lifetime | 71 | NL 2 | 99.32 |
| Nutrition and Health in Aging | Lifetime | 226 | NL 12 | 98.97 |
| Heart Rate Variability and Autonomic Control | Lifetime | 266 | NL 6 | 98.91 |
| Eating Disorders and Behaviors | Lifetime | 143 | NL 7 | 98.86 |
| Diet and metabolism studies | Lifetime | 559 | NL 21 | 98.97 |
| Hormonal Regulation and Hypertension | Lifetime | 292 | NL 11 | 98.48 |
| Maternal Mental Health During Pregnancy and Postpartum | Lifetime | 185 | NL 6 | 98.48 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 169 | NL 9 | 98.49 |
| Health and Wellbeing Research | Lifetime | 185 | NL 7 | 96.85 |
| Cardiovascular Disease and Adiposity | Lifetime | 334 | NL 9 | 98.24 |
| Sleep and related disorders | Lifetime | 273 | NL 5 | 97.93 |
| Child Abuse and Trauma | Lifetime | 258 | NL 5 | 97.99 |
| Genetic Associations and Epidemiology | Lifetime | 333 | NL 15 | 98.25 |
| Bipolar Disorder and Treatment | Lifetime | 309 | NL 5 | 98.21 |
| Telomeres, Telomerase, and Senescence | Lifetime | 159 | NL 7 | 96.78 |
| Aging and Gerontology Research | Lifetime | 130 | NL 9 | 97.27 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 313 | NL 25 | 97.06 |
| Physical Activity and Health | Lifetime | 419 | NL 16 | 97.27 |
| Circadian rhythm and melatonin | Lifetime | 590 | NL 19 | 96.63 |
| Chronic Disease Management Strategies | Lifetime | 604 | NL 50 | 96.53 |
| Schizophrenia research and treatment | Lifetime | 780 | NL 21 | 97.60 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 903 | NL 24 | 96.50 |
| Health, Environment, Cognitive Aging | Lifetime | 301 | NL 8 | 95.78 |
| Genetics, Aging, and Longevity in Model Organisms | Lifetime | 419 | NL 15 | 95.99 |
| Frailty in Older Adults | Lifetime | 633 | NL 31 | 95.95 |
| Adrenal Hormones and Disorders | Lifetime | 688 | NL 37 | 93.92 |
| Digital Mental Health Interventions | Lifetime | 810 | NL 51 | 92.17 |
| Erythropoietin and Anemia Treatment | Lifetime | 638 | NL 21 | 91.75 |
| Psychological Well-being and Life Satisfaction | Lifetime | 921 | NL 41 | 91.78 |
| Heart rate and cardiovascular health | Lifetime | 222 | NL 10 | 86.95 |
| Youth Substance Use and School Attendance | Lifetime | 490 | NL 19 | 83.33 |
| Tryptophan and brain disorders | 2021-2025 | 3 | NL 1 | 99.88 |
| Mental Health Research Topics | 2021-2025 | 4 | NL 2 | 99.83 |
| Stress Responses and Cortisol | 2021-2025 | 4 | NL 1 | 99.68 |
| Child and Adolescent Psychosocial and Emotional Development | 2021-2025 | 70 | NL 6 | 98.70 |
| COVID-19 and Mental Health | 2021-2025 | 128 | NL 2 | 98.44 |
| Treatment of Major Depression | 2021-2025 | 23 | NL 3 | 98.26 |
| Child Abuse and Trauma | 2021-2025 | 46 | NL 1 | 97.50 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | 2021-2025 | 46 | NL 3 | 97.45 |
| Diet and metabolism studies | 2021-2025 | 354 | NL 7 | 96.37 |
| Functional Brain Connectivity Studies | 2021-2025 | 563 | NL 22 | 95.36 |
| Mental Health Treatment and Access | 2021-2025 | 251 | NL 5 | 94.48 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 334 | NL 12 | 93.08 |
| Health, Environment, Cognitive Aging | 2021-2025 | 333 | NL 14 | 88.80 |
| Schizophrenia research and treatment | 2021-2025 | 545 | NL 21 | 91.02 |
| Health, psychology, and well-being | 2021-2025 | 189 | NL 2 | 84.60 |
| Digital Mental Health Interventions | 2021-2025 | 517 | NL 22 | 88.72 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 574 | NL 26 | 82.65 |
| Circadian rhythm and melatonin | 2021-2025 | 883 | NL 19 | 80.82 |
| Child and Adolescent Health | 2021-2025 | 665 | NL 13 | 74.38 |
| Cognitive Abilities and Testing | 2021-2025 | 445 | NL 21 | 66.21 |